Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12970006 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: fluticasone/ salmeterol 125/25 mcg/puff;   Drug: fluticasone/ salmeterol 250/25 mcg/puff
2 Completed A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: fluticasone and salmeterol

Indicates status has not been verified in more than two years